Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Mol Pharm ; 18(11): 4224-4230, 2021 11 01.
Article in English | MEDLINE | ID: mdl-34623822

ABSTRACT

p-Boronophenylmethoxycarbonyl (BPmoc) is a protecting group for amines that is removable by treatment with hydrogen peroxide (H2O2). We prepared BPmoc-modified insulin (BPmoc-Ins) and subcutaneously injected the formulation into diabetic rats. The results demonstrated that BPmoc effectively sealed the blood glucose (Glc)-lowering effects of Ins. Conversely, coinjection of BPmoc-Ins and Glc oxidase (GOx) resulted in reduced blood Glc levels, indicating that Ins was generated from BPmoc-Ins through the following reactions: oxidation of endogenous Glc by GOx; production of H2O2 accompanied by Glc oxidation; removal of BPmoc residues by H2O2. These results show the potential of BPmoc-Ins for a Glc-responsive Ins release system.


Subject(s)
Blood Glucose/drug effects , Diabetes Mellitus, Type 2/drug therapy , Hydrogen Peroxide/chemistry , Insulin, Regular, Human/administration & dosage , Animals , Blood Glucose/analysis , Blood Glucose/chemistry , Boronic Acids/chemistry , Delayed-Action Preparations/administration & dosage , Delayed-Action Preparations/chemistry , Delayed-Action Preparations/pharmacokinetics , Diabetes Mellitus, Type 2/blood , Disease Models, Animal , Drug Liberation , Glucose Oxidase/metabolism , Humans , Hydrogen Peroxide/metabolism , Injections, Subcutaneous , Insulin, Regular, Human/chemistry , Insulin, Regular, Human/pharmacokinetics , Oxidation-Reduction , Rats
SELECTION OF CITATIONS
SEARCH DETAIL
...